Tag: FDA
-
Study: Kids Distracted By Misleading Warnings in E-Cigarette Ads
E-cigarettes and vape companies are courting smokers and non-smokers alike, and they have the advertising to match. Some of the ads from one company, Blu, included “fake” advisories like “WARNING: Contains flavor.” A new study published in the journal Tobacco Control found that boys who saw ads with that type of fake warning were less likely to recall information…
-
President Trump Signs Right-to-Try Act
On Wednesday, May 30, 2018, Pres. Donald Trump signed the Right-to-Try Act, which allows terminally ill patients the ability to try drugs in preliminary testing but not-yet-approved by the Food and Drug Administration. The aim is to make it easier for those patients suffering from fatal illness who have exhausted all other resources to access…
-
Trump Administration Releases Drug Pricing Blueprint
On May 11, The Trump Administration released “American Patients First,” the President’s blueprint to lower drug prices and reduce out-of-pocket costs, along with a request for information. The Blueprint was framed as advancing four specific goals: Reducing list prices; Improving government’s ability to negotiate better prices; Encouraging competition through rapid entry to market of generics and…
-
FDA Classifies Kratom as Opioid
The U.S. Food and Drug Administration has officially classified the plant kratom, originally seen as an opioid alternative, as an opioid itself, stating that compounds in kratom act like prescription-strength opioids. Found in Malaysia, the leaves of the kratom plant are traditionally crushed and made into a tea to treat pain as well as heroin…
-
![What If No One Was on Call [at the Legislature]?](https://alabamamedicine.org/wp-content/uploads/2017/05/Capitol3_banner.jpg)
What If No One Was on Call [at the Legislature]?
2017 Legislative Recap In times of illness, injury and emergency, patients depend on their physicians. But what if no one was on call? Public health would be in jeopardy. However, the same holds true during a legislative session. What would happen if the Medical Association was not on call, advocating for you and your patients…
-
Official Statement on Legalization of Non-FDA Approved Marijuana Substances
March 18, 2016 – “The use of marijuana for the treatment of various symptoms of diseases is an evolving discussion in this state and nation. Two years ago, the Alabama Legislature wisely decided and the Medical Association supported putting the discussion surrounding the efficacy of cannabidiol (CBD) in the treatment of neurologic conditions in children…